Literature DB >> 1658000

Acid hydrolases in early and late endosome fractions from rat liver.

E A Runquist1, R J Havel.   

Abstract

We have examined the distribution of the cation-independent mannose 6-phosphate receptor and five acid hydrolases in early and late endosomes and a receptor-recycling fraction isolated from livers of estradiol-treated rats. Enrichment of mannose 6-phosphate receptor mass relative to that of crude liver membranes was comparable in membranes of early and late endosomes but was even greater in membranes of the receptor-recycling fraction. Enrichment of acid hydrolase activities (aryl sulfatase, N-acetyl-beta-glucosaminidase, tartrate-sensitive acid phosphatase, and cholesteryl ester acid hydrolase) and cathepsin D mass was also comparable in early and late endosomes but was considerably lower in the receptor-recycling fraction. The enrichment of two acid hydrolases, acid phosphatase and cholesteryl ester acid hydrolase, in endosomes was severalfold greater than that of the other three examined, about 40% of that found in lysosomes. Acid phosphatase and cholesteryl ester acid hydrolase were partially associated with endosome membranes, whereas cathepsin D was found entirely in the endosome contents. These findings raise the possibility that lysosomal enzymes traverse early endosomes during transport to lysosomes in rat hepatocytes and suggest that the greater enrichment of some acid hydrolases in endosomes is related to their association with endosome membranes. Despite the substantial enrichment of lysosomal enzymes in hepatocytic endosomes, we found that two, cholesteryl ester acid hydrolase and cathepsin D, did not degrade cholesteryl esters and apolipoprotein B-100 of endocytosed low density lipoproteins in vivo, presumably because they are inactive at the pH within endosomes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658000

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Fluorogenic label for biomolecular imaging.

Authors:  Luke D Lavis; Tzu-Yuan Chao; Ronald T Raines
Journal:  ACS Chem Biol       Date:  2006-05-23       Impact factor: 5.100

2.  A novel size-based sorting mechanism of pinocytic luminal cargoes in microglia.

Authors:  Cong Chen; Hui-Quan Li; Yi-Jun Liu; Zhi-Fei Guo; Hang-Jun Wu; Xia Li; Hui-Fang Lou; Liya Zhu; Di Wang; Xiao-Ming Li; Li Yu; Xuetao Cao; Linrong Lu; Zhihua Gao; Shu-Min Duan
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

Review 3.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

4.  Granulovacuolar degeneration (GVD) bodies of Alzheimer's disease (AD) resemble late-stage autophagic organelles.

Authors:  K E Funk; R E Mrak; J Kuret
Journal:  Neuropathol Appl Neurobiol       Date:  2011-04       Impact factor: 8.090

5.  Endocytosed cation-independent mannose 6-phosphate receptor traffics via the endocytic recycling compartment en route to the trans-Golgi network and a subpopulation of late endosomes.

Authors:  Sharron X Lin; William G Mallet; Amy Y Huang; Frederick R Maxfield
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

6.  Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.

Authors:  J Herz; S Q Qiu; A Oesterle; H V DeSilva; S Shafi; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

7.  Use of glycyl-L-phenylalanine 2-naphthylamide, a lysosome-disrupting cathepsin C substrate, to distinguish between lysosomes and prelysosomal endocytic vacuoles.

Authors:  T O Berg; E Strømhaug; T Løvdal; O Seglen; T Berg
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

8.  Design of a transferrin-proteinase inhibitor conjugate to probe for active cysteine proteinases in endosomes.

Authors:  R Xing; R W Mason
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

Review 9.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

Review 10.  Protective mechanisms by cystatin C in neurodegenerative diseases.

Authors:  Sebastien Gauthier; Gurjinder Kaur; Weiqian Mi; Belen Tizon; Efrat Levy
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.